Development of Lactococcus lactis based combinatorial vaccine using immunodominant antigens of pathogenic Shigella and Escherichia coli o157

dc.contributor.guide	Balakrishna, K.
dc.coverage.spatial
dc.creator.researcher	Sreerohini, S.
dc.date.accessioned	2021-12-08T09:16:29Z
dc.date.available	2021-12-08T09:16:29Z
dc.date.awarded
dc.date.completed	2020
dc.date.registered
dc.description.abstract	newline
dc.description.note
dc.format.accompanyingmaterial	None
dc.format.dimensions
dc.format.extent
dc.identifier.uri	http://hdl.handle.net/10603/350498
dc.language	English
dc.publisher.institution	Department of Biotechnology
dc.publisher.place	Mysore
dc.publisher.university	University of Mysore
dc.relation
dc.rights	university
dc.source.university	University
dc.subject.keyword	Biotechnology and Applied Microbiology
dc.subject.keyword	Intimin (eae)
dc.subject.keyword	Invasive plasmid antigen B (IpaB)
dc.subject.keyword	Lactococcus lactis
dc.subject.keyword	Life Sciences
dc.subject.keyword	LL-Stx2a1
dc.subject.keyword	Microbiology
dc.subject.keyword	Oral vaccine
dc.subject.keyword	Shiga toxin (Stx)
dc.subject.keyword	Toxin neutralization
dc.title	Development of Lactococcus lactis based combinatorial vaccine using immunodominant antigens of pathogenic Shigella and Escherichia coli o157
dc.title.alternative
dc.type.degree	Ph.D.